| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193089 | Annals of Allergy, Asthma & Immunology | 2008 | 7 Pages |
Abstract
Although only 5.9% of US allergists reported using SLIT, most of the 828 surveyed (766 US allergists) viewed SLIT as safe and effective and would consider using SLIT if it were an FDA-approved therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mark H. MD, Michael S. MD, on behalf of the ACAAI Immunotherapy and Diagnostics Committee on behalf of the ACAAI Immunotherapy and Diagnostics Committee,